Germany Plans to Ban Disposable E-Cigarettes

Mar.21.2023
Germany Plans to Ban Disposable E-Cigarettes
Germany plans to ban disposable e-cigarettes due to environmental concerns, with the support of the Federal Environment Minister.

The German Federal Senate has recently developed a plan to ban disposable electronic cigarettes. The plan aims to prohibit disposable e-cigarettes throughout Germany, with the Senate currently urging the federal government to consider implementing the ban. Steffi Lemke, the German Federal Environment Minister, has expressed support for the resolution.


The pressing issue of environmental pollution that needs to be addressed.


Currently, over 5 million disposable e-cigarettes are sold every month in Germany, according to data from the German E-cigarette Trade Association (VdeH). The sales revenue of e-cigarettes in the Federal Republic of Germany is expected to exceed 300 million euros by 2022. E-cigarettes are now commonly sold in supermarkets and convenience stores (Spätis), priced between 7 and 10 euros, and can provide up to 600 puffs for users.


After using disposable e-cigarettes, waste materials such as electronic waste, plastic waste, and used batteries are produced, posing environmental pollution problems. Environmentalists heavily criticize disposable e-cigarettes and condemn the huge waste of resources they cause. The e-liquid inside the device is actually heated by electricity, but lithium-ion batteries are highly flammable, which hinders their recycling.


According to sources from 2FIRSTS, German Federal Environment Minister Svenja Schulze, who supports this resolution, is a member of the Green Party (GRÜNE). The Green Party is an environmental protection-focused political party and the world's oldest green political organization. They advocate for green politics, oppose military expansion, promote peace and anti-nuclear energy, and promote a return to a natural lifestyle.


According to a previous report by 2FIRSTS, Linda Heitmann, a member of the German Green Party, proposed restricting the supply of alcohol and cigarettes, citing them as "the most dangerous drugs to date." Gillian Mackay, a member of the Scottish Green Party, hoped that retailers would treat e-cigarettes like cigarettes and "hide" them from view.


According to reports, in January 2023, the government of the Bavarian state of Germany called for a ban on electronic cigarettes within the European Union and requested that the federal government initiate a movement at the EU level to prohibit the sale of disposable electronic cigarette products. The Bavarian state hopes to reduce the market growth of disposable electronic cigarette products and ultimately decrease the environmental pollution caused by related products through government advocacy.


Teenagers are starting to engage in the trend of using drugs.


In the past year, there has been a significant increase in the number of 14 to 17 year-olds in Germany using e-cigarettes. In a recent representative survey, 15.9% of adolescents in Germany admitted to smoking.


The nicotine levels in electronic cigarettes may be higher than those in traditional cigarettes. Christina Schadt, head of the addiction prevention organization Suchtprävention Berlin, told Stern: "Young people who have not yet smoked are learning about smoking through these products. The sweet taste and smoothness of e-cigarettes give them a false impression that they are consuming something harmless.


Further reading:


The German Green Party proposed restrictions on the sale of tobacco and alcohol.


The era of strict regulation for electronic cigarettes has arrived in Germany. Multiple shops are being inspected.


Reference:


Germany is considering banning disposable e-cigarettes in the near future.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
According to SGST on August 26, 2026, Australia’s Coalition Illegal Tobacco Taskforce released a report recommending an up to 80% cut in tobacco excise to reduce the appeal of the illicit tobacco market. The report claimed organised crime groups now control about 80% of Australia’s tobacco market and argued that high excise rates have widened the price gap between legal and illegal products. The recommendation remains a policy proposal and has not been adopted by the Australian government, which said its focus remains on enforcement, compliance and additional resources.
Aug.27
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Philip Morris International (PMI) has introduced the airport-exclusive limited-edition IQOS ILUMA i PRIME Skylens, the company’s first device created specifically for airport travel retail. Inspired by the world of flight and finished in metallic blue, Skylens debuted at Narita International Airport in Japan before expanding into selected airport duty-free and travel-retail channels across 13 countries in Europe, Asia, the Middle East and Africa. The product retains the existing IQOS ILUMA i PRIME platform, with differentiation centered on airport exclusivity, design and travel-retail execution rather than a new heating architecture.
PMI
Aug.19
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03